Skip to main content
2026 CRT Conference Main banner

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Rasha Al-Lamee is Professor of Cardiology at the National Heart and Lung Institute at Imperial College London. She is a British Heart Foundation intermediate clinical research fellow and a clinical trialist.

She designed and led the only placebo-controlled trials of coronary angioplasty, ORBITA and ORBITA-2. She was also the chief investigator of the ORBITA-COSMIC and ORBITA-STAR studies. She led The Lancet commission on atherosclerotic heart disease. She is currently leading the ORBITA-FIRE, ORBITA-MOON and ORBITA-SOLAR trials, has over 160 peer-reviewed publications and a h-index of 44.

She is a deputy editor at JACC. She is Deputy Director and head of the second year of Medicine at Imperial College London. She is co-head of the cardiovascular theme of the Imperial NIHR Biomedical Research Centre.









Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Presentation(s):